BioVentures

QIC BioVentures (QBV) is QIC’s venture capital arm, investing in and actively managing companies in the biotechnology and life sciences sector.

QBV manages the Queensland BioCapital Funds No. 1 and No. 2 (collectively termed QBF) which were established in 2002 and are fully invested over 17 portfolio companies. QBF portfolio companies are commercialising early-stage technologies primarily in the fields of medical devices and drug development, with significant diversification in terms of technology and therapeutic focus.

In 2009, QBV received further top-up funding to progress and add value to the QBF investee companies. QBV’s second fund, Innovis Investments Australia Fund, has invested in eight companies, four of which are co-investments with QBF. In addition, QBV is a general partner for the Innovis Investments LP (the US arm of the Innovis Funds); both Innovis funds were established in 2005. QBV also manages the limited partner relationship with HealthCare Ventures (established in 2010).
 
QBV’s investee companies offer demonstrably sound science, strong intellectual property and the potential to develop a well-differentiated product that attracts a sizeable market. Following an investment, QBV seeks to have an active role in managing the portfolio company with a significant equity position in the form of preference shares with specified rights.

Contact Us

To find out more about QIC BioVentures, please contact:

Moira Crowson
Business Administrator
p: +61 7 3009 6850
e: info@qbv.qic.com